Showing 2601-2610 of 2894 results for "".
- Patients Treated with Dysport Highly Satisfied with Twice-Yearly Treatmentshttps://modernaesthetics.com/news/patients-treated-with-dysport-highly-satisfied-with-twice-yearly-treatments/2472933/Topline results of DREAM (Dysport Real-world Evaluation and Measured satisfaction study), a clinical study of Dysport (abobotulinumtoxinA) for injection, showed that 95 percent of patients treated with Dysport achieved high levels of satisfaction with two treatments per
- Think Social Media Helps Grow Your Practice? Think Again, New Survey Suggestshttps://modernaesthetics.com/news/think-social-media-helps-grow-your-practice-think-again-new-survey-suggests/2472930/Patients often do not take social media into consideration when looking for a dermatologist, according to a survey from researchers at the George Washington University. The survey appears in the Journal of Dru
- Galderma's Restylane Kysse FDA Approved for Lip Augmentation and Upper Perioral Rhytidshttps://modernaesthetics.com/news/galdermas-restylane-kysse-fda-approved-for-lip-augmentation-and-upper-perioral-rhytids/2472927/The FDA recently approved Galderma'a Restylane Kysse for lip augmentation and the correction of upper perioral rhytids in adults over the age of 21. Restylane Kysse is the first hyaluronic acid (HA) filler specifically indicated for the lips using XpresHAn Technology globally referred to as t
- Professional Golfer Jessica Korda Named Isdin's New Sports Ambassadorhttps://modernaesthetics.com/news/professional-golfer-jessica-korda-named-isdins-new-sports-ambassador/2472904/Professional golfer and LPGA star Jessica Korda is ISDIN’s new sports ambassador. As part of the campaign, Korda is sharing how she keeps her skin looking its best on and off the golf course with ISDIN products. "ISDIN formulates unique and innovative products with
- Meet Zaffiro, Neauvia’s Two-Part Solution to Skin Rejuvenationhttps://modernaesthetics.com/news/meet-zaffiro-neuvias-two-part-solution-to-skin-rejuvenation/2472893/Neauvia introduced Zaffiro to the media at an event held in New York City’s Hudson Yards, featuring New York City dermatologist Amy Lewis, MD Launched in the US in late 2019, the Zaffiro device is a dual facial rejuvenation system combining wa
- BTL Introduces Emsella Applicator for Emsculpt Platformhttps://modernaesthetics.com/news/btl-introduces-emsella-applicator-for-emsculpt-platform/2472892/BTL is launching the new Emsella applicator with up to 2.5 Tesla (T) to treat all forms of male and female urinary incontinence. Building upon the existing clearances for Emsculpt for the abdomen, buttocks, thighs, arms and calves, the new Emsella applicator makes Emsculpt the first system to tre
- Molly Sims Named New SoME Skincare Brand Ambassadorhttps://modernaesthetics.com/news/molly-sims-named-new-some-skincare-brand-ambassador/2472887/Molly Sims is Brand Ambassador for Aesthetics Biomedical’s SoME Skincare That's All You, a patented personalized Platelet Rich Plasma (PRP) skincare for at-home use. SoME That's All You is combined with your PRP b
- BTL Suit Alleges False Advertising by Allerganhttps://modernaesthetics.com/news/btl-suit-alleges-false-advertising-by-allergan-1/2472885/In a new lawsuit filed this week, BTL Industries alleges that Allergan launched a wide-ranging false and misleading advertising campaign relating to BTL's EMSCULPT device for non-invasive muscle toning and body shaping. The suit alleges that Allergan's marketing, sales materials, and soci
- Modern Aesthetics® Magazine’s Exclusive First Look at the Annual AAFPRS Survey Resultshttps://modernaesthetics.com/news/modern-aesthetics-magazines-exclusive-first-look-at-annual-aafprs-survey/2472881/Facial plastic surgery procedures increased 6 percent last year compared to 2018, according to the
- Allergan's New Philanthropic Program Will Benefit Kids with Upper Limb Spasticityhttps://modernaesthetics.com/news/allergans-new-philanthropic-program-will-benefit-kids-with-upper-limb-spasticity/2472879/Allergan is launching the Be The Difference philanthropic program to support children and their families who may benefit from treatment with Botox (onabotulinumtoxinA) for pediatric upper limb spasticity. Botox is approved to treat increased muscle stiffness in children 2 to 17 years of